Literature DB >> 14693614

The sunburn pain model: the stability of primary and secondary hyperalgesia over 10 hours in a crossover setting.

Burkhard Gustorff1, Sebastian Anzenhofer, Thomas Sycha, Stephan Lehr, Hans G Kress.   

Abstract

UNLABELLED: It was our aim to study the within-day stability and between-day repeatability of ultraviolet B (UVB) light-induced primary and secondary hyperalgesia over 10 h. Twenty hours after UVB irradiation of a skin spot (r = 2.5 cm) on the upper leg of 8 healthy volunteers the areas of secondary hyperalgesia to pinprick and pain tolerance thresholds to heat (HPTT) and electrical stimuli (5 and 250 Hz, electrical pain tolerance thresholds [EPTT]) were assessed. Measurements were repeated for 10 h at 2-h intervals and in 2 different sessions. Large areas of secondary hyperalgesia to pin prick were observed (5995 mm(2); SD, 1645). Primary hyperalgesia was evidenced by significant decreases of HPTT (mean difference, 6.5 degrees C; 95% confidence interval, 6.1-6.8; P < 0.001) and EPTT at 250 Hz (mean difference, 0.45 mA; 95% confidence interval, 0.13-0.78; P < 0.05) compared to normal skin. There was no trend within one session of either primary (P = 0.14 for HPTT) or secondary hyperalgesia (P = 0.95) and no difference between the two sessions (primary hyperalgesia, P = 0.28; secondary hyperalgesia, P = 0.07). The sunburn pain model provides a long time course of stable hyperalgesia with a high within-day stability and between-day repeatability for primary and secondary hyperalgesia. IMPLICATIONS: The sunburn pain model provides a long time course of stable hyperalgesia with a high within-day stability and between-day repeatability for primary and secondary hyperalgesia.

Entities:  

Mesh:

Year:  2004        PMID: 14693614     DOI: 10.1213/01.ane.0000093224.77281.a5

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  21 in total

1.  Effect of transdermal opioids in experimentally induced superficial, deep and hyperalgesic pain.

Authors:  T Andresen; C Staahl; A Oksche; H Mansikka; L Arendt-Nielsen; A M Drewes
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 2.  [Potential antinociceptive mechanisms of botulinum toxin].

Authors:  K R Aoki; J Francis; W H Jost
Journal:  Schmerz       Date:  2006-09       Impact factor: 1.107

3.  Heat-rekindling in UVB-irradiated skin above NGF-sensitized muscle: experimental models of prolonged mechanical hypersensitivity.

Authors:  Silvia Lo Vecchio; Sara Finocchietti; Parisa Gazerani; Lars J Petersen; Lars Arendt-Nielsen; Thomas Graven-Nielsen
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2014-10-11

4.  A novel model of inflammatory pain in human skin involving topical application of sodium lauryl sulfate.

Authors:  L J Petersen; A M Lyngholm; L Arendt-Nielsen
Journal:  Inflamm Res       Date:  2010-04-01       Impact factor: 4.575

5.  Effects of intrathecal ketorolac on human experimental pain.

Authors:  James C Eisenach; Regina Curry; Chuanyao Tong; Timothy T Houle; Tony L Yaksh
Journal:  Anesthesiology       Date:  2010-05       Impact factor: 7.892

6.  Effect of Intravenous Alfentanil on Nonpainful Thermally Induced Hyperalgesia in Healthy Volunteers.

Authors:  Carolyn Schifftner; Gery Schulteis; Mark S Wallace
Journal:  J Clin Pharmacol       Date:  2017-05-02       Impact factor: 3.126

7.  Sensory defunctionalization induced by 8% topical capsaicin treatment in a model of ultraviolet-B-induced cutaneous hyperalgesia.

Authors:  Silvia Lo Vecchio; Hjalte Holm Andersen; Jesper Elberling; Lars Arendt-Nielsen
Journal:  Exp Brain Res       Date:  2021-07-24       Impact factor: 1.972

Review 8.  Use of sensory methods for detecting target engagement in clinical trials of new analgesics.

Authors:  Boris A Chizh; Christine N Sang
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

Review 9.  Translating nociceptive processing into human pain models.

Authors:  Martin Schmelz
Journal:  Exp Brain Res       Date:  2009-04-29       Impact factor: 1.972

10.  [Topical application of morphine and buprenorphine gel has no effect in the sunburn model].

Authors:  J Draxler; M Schuch; A Paul; T Sycha; C Valenta; R Likar; B Gustorff
Journal:  Schmerz       Date:  2008-10       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.